FOXJ1 Antibody

What is FOXJ1 and why is it important in research?

FOXJ1 (Forkhead box protein J1) is a 45-50 kDa transcription factor belonging to the Forkhead-box (FOX) family of winged-helix transcription factors. In humans, the canonical protein consists of 421 amino acids and contains one fork-head DNA binding domain (aa 120-210) . FOXJ1 is crucial in research because it plays dual critical roles: it is specifically required for the formation of motile cilia in epithelial tissues and also functions as an immunoregulatory transcription factor that suppresses T cell activity and spontaneous autoimmunity through the repression of NFκB activity . Its expression is high in ciliated epithelial cells and low in naive T and B cells, making it an important marker for studying ciliated cell differentiation and immune regulation .

What tissue types typically express FOXJ1?

FOXJ1 expression is notably observed in tissues with highly ciliated cells, including:

• Nasopharynx and bronchus

• Fallopian tube and endometrium

• Conducting airways and lung tissue

• Choroid plexus and ependyma of the brain

• Testis and oviduct

• Embryonic left/right organizer (LRO) with motile mono-cilia

The protein is primarily localized in the nucleus, though cytoplasmic staining has also been observed in some cell types .

What are the most common applications for FOXJ1 antibodies?

Based on the validation data from multiple sources, FOXJ1 antibodies are commonly used in:

Always optimize dilutions for each specific application and sample type .

How should I select between monoclonal and polyclonal FOXJ1 antibodies?

The choice depends on your experimental goals:

Monoclonal antibodies (e.g., clone 2A5 or clone 407003 ):

• Provide higher specificity for a single epitope

• Offer better consistency between lots

• Ideal for experiments requiring precise epitope targeting

• Recommended for applications where background must be minimized

Polyclonal antibodies (e.g., catalog #25903-1-AP or #AF3619 ):

• Recognize multiple epitopes on the FOXJ1 protein

• Provide stronger signals in applications like IHC and WB

• Useful when protein conformation may be altered by experimental conditions

• Better for detecting FOXJ1 across multiple species due to epitope diversity

Consider your specific application, required sensitivity, and experimental conditions when making this selection .

What controls should I include when using FOXJ1 antibodies?

For rigorous experimental design, include these controls:

• Positive tissue controls: Use tissues known to express FOXJ1, such as:

  • Mouse tracheal epithelial cells and testes

  • Mouse or rat liver tissue

  • Human pancreatic adenocarcinoma cell line (Capan-1) or breast cancer cell line (T47D)

• Negative controls:

  • Isotype control antibody (matching host species and isotype)

  • Secondary antibody-only control

  • Tissues known to lack FOXJ1 expression

• Validation controls:

  • FOXJ1 knockdown/knockout samples when available

  • Blocking peptide competition assays

  • Multiple antibodies targeting different FOXJ1 epitopes for confirmation

These controls help distinguish specific from non-specific staining and validate antibody performance .

How can I effectively use FOXJ1 antibodies to study ciliogenesis in vitro?

To study ciliogenesis using FOXJ1 antibodies:

• Cell culture model selection:

  • Use air-liquid interface (ALI) cultures of primary airway epithelial cells

  • HEK293 cells have been validated for FOXJ1 expression studies

  • BG01V human embryonic stem cells differentiated to early proximal lung progenitors

• Experimental approach:

  • Implement lentivirus-mediated FOXJ1 expression systems (e.g., Lenti-FOXJ1 under CMV promoter)

  • Monitor ciliogenesis at different timepoints via immunofluorescence

  • Co-stain with other ciliary markers (acetylated tubulin, basal body markers)

• Analysis methods:

  • Quantify cilia length, number, and FOXJ1 expression levels

  • Assess the impact of environmental factors (e.g., cigarette smoke) on FOXJ1 expression and cilia growth

  • Correlate FOXJ1 expression with calpastatin levels, which is necessary for basal body anchoring

This approach allows for comprehensive investigation of FOXJ1's role in the molecular mechanisms of ciliogenesis .

What are the optimal fixation and antigen retrieval methods for FOXJ1 immunohistochemistry?

For optimal FOXJ1 detection in immunohistochemistry:

Fixation:

• Formalin-fixed paraffin-embedded (FFPE) tissues have been successfully used with FOXJ1 antibodies

• For immunocytochemistry, immersion fixation with paraformaldehyde is recommended

Antigen Retrieval:

• TE buffer pH 9.0 is suggested as the primary antigen retrieval method

• Alternatively, citrate buffer pH 6.0 can be used if TE buffer does not yield optimal results

• For flow cytometry, paraformaldehyde fixation followed by saponin permeabilization has been validated

These methods help preserve epitope integrity while ensuring accessibility for antibody binding .

How can I troubleshoot weak or non-specific FOXJ1 antibody signals?

When encountering issues with FOXJ1 antibody performance:

For weak signals:

• Optimize antibody concentration - try a range between 1-10 μg/mL for most applications

• Extend primary antibody incubation time (e.g., 3 hours at room temperature or overnight at 4°C)

• Enhance signal using more sensitive detection systems (HRP-polymers, tyramide signal amplification)

• Ensure proper antigen retrieval as described in question 3.1

For non-specific signals:

• Include proper blocking steps (use 0.1% BSA in PBS for flow cytometry)

• Reduce antibody concentration or implement more stringent washing

• Use highly purified antibodies (>90% purity as determined by SDS-PAGE)

• Test multiple antibodies targeting different epitopes of FOXJ1

For Western blot specific issues:

• The observed molecular weight for FOXJ1 is typically 50-55 kDa, which may differ slightly from the calculated 45.2 kDa

• Ensure reducing conditions and appropriate buffer systems (e.g., Immunoblot Buffer Group 1)

Careful optimization of these parameters will help maximize signal-to-noise ratio .

How can FOXJ1 antibodies be used to investigate ciliopathies and heterotaxy syndromes?

FOXJ1 antibodies provide valuable tools for studying ciliopathies and heterotaxy:

• Clinical sample analysis:

  • Examine FOXJ1 expression patterns in patient-derived samples with suspected ciliopathies

  • Assess co-expression with other ciliary proteins in patients with primary ciliary dyskinesia (CILD43)

  • Compare FOXJ1 levels in patients with heterotaxy versus controls

• Functional studies:

  • Investigate effects of FOXJ1 mutations on protein localization and function

  • Use FOXJ1 antibodies to characterize dominant-negative FOXJ1 mutations identified in heterotaxy families

  • Assess impact of mutations on downstream ciliary gene activation

• Developmental biology applications:

  • Study FOXJ1 expression during embryonic left-right patterning

  • Analyze FOXJ1 localization in the embryonic left/right organizer (LRO)

  • Correlate FOXJ1 expression with cilia formation and function during development

These approaches can help elucidate how FOXJ1 dysfunction contributes to human diseases including hydrocephalus, laterality defects, and mucociliary clearance disorders .

What approaches can be used to study FOXJ1's role in immune regulation?

To investigate FOXJ1's immunoregulatory functions:

• Molecular mechanism studies:

  • Use co-immunoprecipitation with FOXJ1 antibodies to identify interaction partners in immune cells

  • Study how FOXJ1 represses NFκB activity through IκBβ induction

  • Examine FOXJ1's impact on germinal center formation and Th1 activation

• Animal models:

  • Apply FOXJ1 antibodies for immunophenotyping in FOXJ1-deficient models

  • Investigate autoimmune phenotypes in FOXJ1 knockout or mutant models

  • Study FOXJ1 expression changes during immune cell activation and differentiation

• Autoimmune disease research:

  • Compare FOXJ1 expression levels in patients with systemic lupus erythematosus or rheumatoid arthritis versus healthy controls

  • Correlate FOXJ1 levels with disease activity markers

  • Examine the relationship between FOXJ1 expression and B cell germinal center formation in autoimmune conditions

These approaches can help clarify FOXJ1's role in preventing spontaneous autoimmunity and its potential as a therapeutic target for autoimmune diseases .

How can ChIP techniques with FOXJ1 antibodies identify novel target genes?

Chromatin immunoprecipitation (ChIP) with FOXJ1 antibodies can reveal its genomic targets:

• ChIP-seq methodology:

  • Select ChIP-validated FOXJ1 antibodies (polyclonal antibodies often work best for ChIP)

  • Target tissues with high FOXJ1 expression (ciliated epithelial cells, lung, brain ependyma)

  • Look for enrichment at consensus DNA binding sequences: 5'-HWDTGTTTGTTTA-3' or 5'-KTTTGTTGTTKTW-3'

• Bioinformatic analysis:

  • Identify genes associated with motile cilia assembly that are direct FOXJ1 targets

  • Examine enrichment for genes involved in NFκB pathway regulation

  • Compare FOXJ1 binding sites across different cell types (immune vs. epithelial)

• Functional validation:

  • Confirm direct target genes using reporter assays

  • Validate the regulation of CFAP157 and other ciliary assembly genes

  • Investigate how FOXJ1 binding correlates with calpastatin expression

This approach allows for comprehensive mapping of FOXJ1's transcriptional targets and provides insight into its dual roles in ciliogenesis and immune regulation .

How should I interpret variations in FOXJ1 molecular weight across different experimental systems?

When analyzing FOXJ1 Western blot results:

• Expected molecular weights:

  • The calculated molecular weight of human FOXJ1 is 45.2 kDa

  • The observed molecular weight is typically 50-55 kDa in most experimental systems

  • In Simple Western systems, FOXJ1 may appear at approximately 58 kDa

• Interpreting variations:

  • Post-translational modifications (phosphorylation, glycosylation) can increase apparent molecular weight

  • Different isoforms may exist in different tissues

  • Sample preparation conditions (reducing vs. non-reducing) may affect migration

  • Experimental factors such as gel percentage and buffer systems influence apparent size

• Verification approach:

  • Use multiple antibodies targeting different epitopes to confirm specificity

  • Include positive control lysates with known FOXJ1 expression

  • Consider protein sequence variations between species (human FOXJ1 shares 87% amino acid identity with mouse and rat FOXJ1)

These considerations help ensure accurate interpretation of FOXJ1 detection despite size variations .

What are the expected expression patterns of FOXJ1 during cellular differentiation?

FOXJ1 expression follows specific patterns during differentiation:

• In epithelial differentiation:

  • FOXJ1 serves as an early marker of epithelial cell differentiation, recovery, and function

  • Expression increases during the differentiation of airway progenitors to ciliated cells

  • In embryonic stem cells differentiated to early proximal lung progenitors, FOXJ1 localizes primarily to nuclei

• In immune cell development:

  • Expression is low in naive T and B cells

  • Cellular activation results in downregulation of FOXJ1

  • FOXJ1 deficiency in B cells leads to spontaneous germinal center formation

• During ciliogenesis:

  • FOXJ1 expression precedes the appearance of motile cilia

  • It activates the transcription of genes mediating motile cilia assembly

  • Expression patterns may differ between primary cilia and motile cilia formation

Understanding these patterns is essential for correctly interpreting experimental results in developmental and differentiation studies .